Back
Corporate News
Gufic Biosciences shareholders to vote on director reappointment and auditor remuneration
12-Aug-2026, 10:18
Gu?c Biosciences Limited will seek shareholder approval at its 42nd Annual General Meeting on July 31, 2026, for two key resolutions. Shareholders will vote on an ordinary resolution to ratify the remuneration of the company’s Cost Auditor, requiring a simple majority. Additionally, a special resolution is slated for a vote to re-appoint Whole Time Director Pankaj Jayakumar Gandhi for a further five years, until September 6, 2031. A separate special resolution is also required due to Mr. Gandhi’s age, allowing him to continue serving past 70. Mr. Gandhi, son of Chairman & Managing Director Jayesh P. Choksi, holds no shares in the company and a detailed profile, including his experience and committee memberships, is available in Annexure A. Shareholders are reminded that special resolutions require a 75% majority to pass and must review all relevant documentation before casting their votes.
Gu?c Biosciences Limited will seek shareholder approval at its 42nd Annual General Meeting on July 31, 2026, for two key resolutions. Shareholders will vote on an ordinary resolution to ratify the remuneration of the company’s Cost Auditor, requiring a simple majority. Additionally, a special resolution is slated for a vote to re-appoint Whole Time Director Pankaj Jayakumar Gandhi for a further five years, until September 6, 2031. A separate special resolution is also required due to Mr. Gandhi’s age, allowing him to continue serving past 70. Mr. Gandhi, son of Chairman & Managing Director Jayesh P. Choksi, holds no shares in the company and a detailed profile, including his experience and committee memberships, is available in Annexure A. Shareholders are reminded that special resolutions require a 75% majority to pass and must review all relevant documentation before casting their votes.